ZA200501590B - 6,7-Dihydro-5H-pyrazoloÄ1,2-aÜpyrazol-1-ones whichcontrol inflammatory cytokines. - Google Patents

6,7-Dihydro-5H-pyrazoloÄ1,2-aÜpyrazol-1-ones whichcontrol inflammatory cytokines.

Info

Publication number
ZA200501590B
ZA200501590B ZA200501590A ZA200501590A ZA200501590B ZA 200501590 B ZA200501590 B ZA 200501590B ZA 200501590 A ZA200501590 A ZA 200501590A ZA 200501590 A ZA200501590 A ZA 200501590A ZA 200501590 B ZA200501590 B ZA 200501590B
Authority
ZA
South Africa
Prior art keywords
dihydro
interleukin
inflammatory cytokines
aüpyrazol
whichcontrol
Prior art date
Application number
ZA200501590A
Other languages
English (en)
Inventor
Michael Philip Clark
Matthew John Laufersweiler
Adam Golebiowski
Mark P Sabat
Todd Andrew Brugel
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of ZA200501590B publication Critical patent/ZA200501590B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4162—1,2-Diazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA200501590A 2002-09-18 2005-02-23 6,7-Dihydro-5H-pyrazoloÄ1,2-aÜpyrazol-1-ones whichcontrol inflammatory cytokines. ZA200501590B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/246,214 US6730668B2 (en) 2001-09-20 2002-09-18 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines

Publications (1)

Publication Number Publication Date
ZA200501590B true ZA200501590B (en) 2006-02-22

Family

ID=32028948

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200501590A ZA200501590B (en) 2002-09-18 2005-02-23 6,7-Dihydro-5H-pyrazoloÄ1,2-aÜpyrazol-1-ones whichcontrol inflammatory cytokines.

Country Status (20)

Country Link
US (3) US6730668B2 (ru)
EP (1) EP1539761B1 (ru)
JP (1) JP2006502189A (ru)
KR (3) KR20070087684A (ru)
CN (1) CN1315834C (ru)
AT (1) ATE429434T1 (ru)
AU (1) AU2003218280B8 (ru)
BR (1) BR0314292A (ru)
CA (1) CA2496500A1 (ru)
DE (1) DE60327328D1 (ru)
ES (1) ES2322046T3 (ru)
IL (1) IL166822A0 (ru)
MA (1) MA27434A1 (ru)
MX (1) MXPA05002984A (ru)
NO (1) NO20051686L (ru)
NZ (1) NZ538197A (ru)
PL (1) PL376086A1 (ru)
RU (1) RU2289584C2 (ru)
WO (1) WO2004026878A1 (ru)
ZA (1) ZA200501590B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6849627B2 (en) * 2001-09-20 2005-02-01 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
US6821971B2 (en) * 2001-09-20 2004-11-23 The Procter & Gamble Company Fused pyrazolone compounds which inhibit the release of inflammatory cytokines
US6730668B2 (en) * 2001-09-20 2004-05-04 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
US7326714B2 (en) * 2001-09-20 2008-02-05 The Procter & Gamble Company 6,7-Dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
US7473695B2 (en) * 2001-10-22 2009-01-06 Mitsubishi Tanabe Pharma Corporation 4-imidazolin-2-one compounds
US7482356B2 (en) * 2003-11-10 2009-01-27 The Procter & Gamble Company Bicyclic pyrazolone cytokine inhibitors
DE102008060549A1 (de) 2008-12-04 2010-06-10 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung
CN102438993A (zh) * 2009-05-19 2012-05-02 陶氏益农公司 用于控制真菌的化合物和方法
US10512628B2 (en) 2016-04-24 2019-12-24 Solano S.P. Ltd. Dinotefuran liquid flea and tick treatment

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1124982A (en) 1965-02-09 1968-08-21 Lepetit Spa Diazabicyclo octanes and derivatives thereof
CH529154A (fr) 1969-10-27 1972-10-15 Lepetit Spa Procédé de préparation de pyrazolo (1,2-b) phtalazine-1,5 (10H)-diones
US6472416B1 (en) * 1999-08-27 2002-10-29 Abbott Laboratories Sulfonylphenylpyrazole compounds useful as COX-2 inhibitors
DE10004157A1 (de) * 2000-02-01 2001-08-02 Merckle Gmbh Chem Pharm Fabrik 4-Pyridyl-und 2,4-Pyrimidinyl-substituierte Pyrrolderivate und ihre Anwendung in der Pharmazie
US6821971B2 (en) * 2001-09-20 2004-11-23 The Procter & Gamble Company Fused pyrazolone compounds which inhibit the release of inflammatory cytokines
US6730668B2 (en) * 2001-09-20 2004-05-04 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines

Also Published As

Publication number Publication date
IL166822A0 (en) 2006-01-15
BR0314292A (pt) 2005-12-13
JP2006502189A (ja) 2006-01-19
CA2496500A1 (en) 2004-04-01
ATE429434T1 (de) 2009-05-15
DE60327328D1 (de) 2009-06-04
KR100842191B1 (ko) 2008-06-30
PL376086A1 (en) 2005-12-12
US6730668B2 (en) 2004-05-04
AU2003218280B2 (en) 2008-05-15
MXPA05002984A (es) 2005-06-22
NO20051686L (no) 2005-04-05
CN1315834C (zh) 2007-05-16
AU2003218280A1 (en) 2004-04-08
KR20070051374A (ko) 2007-05-17
NZ538197A (en) 2007-01-26
AU2003218280B8 (en) 2008-06-26
KR20050057444A (ko) 2005-06-16
EP1539761B1 (en) 2009-04-22
US6960593B2 (en) 2005-11-01
EP1539761A1 (en) 2005-06-15
RU2289584C2 (ru) 2006-12-20
CN1681819A (zh) 2005-10-12
ES2322046T3 (es) 2009-06-16
US20040058944A1 (en) 2004-03-25
RU2005111220A (ru) 2006-02-27
US7368455B2 (en) 2008-05-06
WO2004026878A1 (en) 2004-04-01
MA27434A1 (fr) 2005-07-01
US20030134867A1 (en) 2003-07-17
KR20070087684A (ko) 2007-08-28
US20050282844A1 (en) 2005-12-22

Similar Documents

Publication Publication Date Title
ZA200501590B (en) 6,7-Dihydro-5H-pyrazoloÄ1,2-aÜpyrazol-1-ones whichcontrol inflammatory cytokines.
NO20054959D0 (no) Fremgangsmater for behandling av interleukin-6 relaterte sykdommer
MXPA03008955A (es) Agente terapeutico para enfermedades de tipo artritides cronicas o enfermedades relacionadas con la ninez.
WO2001087328A3 (en) Interleukin-1 inhibitors in the treatment of diseases
WO2003014309A3 (en) Interleukin-1 receptors in the treatment of diseases
ES2193256T3 (es) Aril pirroles 2-sustituidos, composiciones que contienen tales compuestos y procedimientos de uso.
SI1725544T1 (sl) 3-(4-heterociklil-1,2,3-triazol-1-il)-N-aril-benzamidi kot inhibitorji proizvodnje citokinov za zdravljenje kroničnih vnetnih bolezni
MY138373A (en) Cytokine inhibitors
IS2690B (is) 5-fenýl-4-metýl-þíasól-2-ýl-amínafleiður sem hemlar fosfatídýlínósítól 3 kínasaensíma (PI3) til að meðhöndla bólgusjúkdóma í öndunarvegi
MX2009005398A (es) Metodos para el tratamiento de enfermedades inflamatorias cronicas usando antagonista de gm-csf.
ATE365733T1 (de) Zusammensetzungen brauchbar als protein-kinase- inhibitoren
MXPA04003439A (es) Compuestos de maleimida 3,4 disustituidos como antagonistas de receptor de quimiocina cxc.
IL163090A (en) Nicotinamide derivates, pharmaceutical compositions comprising them and their use for manufacture of medicaments useful as p38 inhibitors
BRPI0409417A (pt) método para usar um composto, composto, e, composição
CA2492804A1 (en) Novel inhibitors of kinases
NO20062061L (no) Nye substituerte, 4-amino-tiazolo[4,5-D]pyriminder, nyttige som kjemokinreseptorantagonister, ESP. CX3CR1
HRP20070020T3 (en) 1-(2h-pyrazol-3-yl)-3- 4-[1-(benzoyl)-piperidin-4-ylmethyl]-phenyl -urea derivatives and related compounds as inhibitors of p38 kinase and/or tnf inhibitors for the treatment of inflammations
WO2006087644A3 (en) Macrolides with anti-inflammatory activity
EA200801711A1 (ru) Пролекарства возбуждающих аминокислот
BRPI0511124A (pt) pró-drogas de inibidores de erk proteìna cinase de pirrolilpirimidina
AP1564A (en) Piperazinyl sulfonic acid derivatives, their pharmaceutical compositions and methods of use.
TW200731972A (en) Methods and compositions for bactericide, bacteriostatic and anti-inflammation
PT1562954E (pt) Antagonistas de ccr1 para o tratamento da doenca desmielinzante inflamatoria i.a.
AU2003265924A1 (en) Benzimidazolones and their use as cytokine inhibitors
EA200100876A2 (ru) Фармацевтическая композиция для предупреждения или лечения заболевания, связанного с избыточным продуцированием il-12